의약품 포장 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 소재별, 제품별, 약물전달별, 최종 용도별, 지역별 & 경쟁(2025-2030년)
Pharmaceutical Packaging Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Material, By Product, By Drug Delivery, By End Use, By Region & Competition, 2020-2030F
상품코드:1812006
리서치사:TechSci Research
발행일:2025년 09월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
의약품 포장 시장은 2024년에 1,531억 달러로 평가되었습니다. 2030년에는 CAGR 9.68%로 2,665억 4,000만 달러에 이를 것으로 예측됩니다.
세계 의약품 포장 시장은 의약품 생산량의 급증, 규제 준수에 대한 중요성 증가, 약물 전달 시스템의 끊임없는 기술 혁신에 힘입어 급속한 구조적 진화를 겪고 있습니다. 포장은 의약품 가치사슬에서 제품의 안정성, 환자 안전, 규제 투명성을 보장하는 전략적 원동력이 되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
1,531억 달러
시장 규모 : 2030년
2,665억 4,000만 달러
CAGR : 2025-2030년
9.68%
급성장 부문
플라스틱 및 폴리머
최대 시장
북미
이러한 변화는 생물학적 제제, 특수 의약품, 맞춤형 치료에 대한 수요 증가로 인해 더욱 가속화되고 있으며, 이러한 의약품은 모두 보다 정교하고 종종 맞춤형 포장 형태가 필요합니다. 첨단 재료 과학, 디지털 추적성 솔루션, 세계 규제 기준 강화 등 제약 포장의 미래를 형성하는 모든 요소에 힘입어 제약 포장 시장은 강력하고 지속적인 성장세를 보이고 있습니다.
시장 성장 촉진요인
세계 의약품 생산량 증가
주요 시장 이슈
엄격하게 진화하는 규제 요건
규제는 안전을 보장하는 한편, 비용과 복잡성을 증가시키고, 혁신을 지연시키고, 투자를 억제하고, 제조업체의 세계 확장 능력을 떨어뜨릴 수 있습니다.
The Pharmaceutical Packaging market was valued at USD 153.10 Billion in 2024 and is expected to reach USD 266.54 Billion by 2030 with a CAGR of 9.68%. The Global Pharmaceutical Packaging Market is experiencing rapid structural evolution, fueled by the surge in pharmaceutical manufacturing volumes, heightened emphasis on regulatory compliance, and continuous innovation in drug delivery systems. Packaging has become a strategic enabler in the pharmaceutical value chain ensuring product stability, patient safety, and regulatory transparency, while also improving logistical efficiency across increasingly complex global supply networks.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 153.10 Billion
Market Size 2030
USD 266.54 Billion
CAGR 2025-2030
9.68%
Fastest Growing Segment
Plastics & Polymers
Largest Market
North America
This transformation is further accelerated by the growing demand for biologics, specialty medicines, and personalized therapies, all of which require more sophisticated and often customized packaging formats. The market is set for robust and sustained growth, underpinned by advanced material science, digital traceability solutions, and the tightening of global regulatory standards all reshaping the future of pharmaceutical packaging.
Key Market Drivers
Rising Global Pharmaceutical Production
The rising global pharmaceutical production is a powerful driver fueling the growth of the Global Pharmaceutical Packaging Market, as it directly increases the demand for diverse, high-quality, and regulatory-compliant packaging solutions. As pharmaceutical manufacturing scales up across both developed and emerging markets to meet growing healthcare needs, the need for robust, efficient, and specialized packaging becomes indispensable. As pharmaceutical output increases globally, so does the volume of drugs that require packaging from tablets and capsules to injectables, powders, and liquids. Every drug unit must be securely packaged for protection, distribution, and administration. This surge in production automatically translates into a higher demand for primary, secondary, and tertiary packaging materials, ranging from blister packs and bottles to cartons, shrink wraps, and pallets.
Each year, the expiration of patents for blockbuster drugs results in substantial revenue losses for pharmaceutical companies, often amounting to billions of dollars. Between 2025 and 2030, the industry is bracing for one of the most significant patent cliffs in its history, with approximately 200 high-revenue drugs expected to lose exclusivity. This wave of expirations threatens to impact an estimated USD 236 billion to USD 400 billion in global pharmaceutical revenues, intensifying competitive pressures and accelerating the shift toward generics and biosimilars. The expiration of patents for numerous blockbuster drugs has led to a sharp rise in generic drug production, especially in cost-sensitive markets such as India, Brazil, and Southeast Asia. Generic drug manufacturers produce in high volumes and operate on tight margins, creating a massive requirement for cost-effective, scalable, and regulatory-approved packaging solutions. This has resulted in significant packaging consumption globally, especially in the primary packaging category. With the pharmaceutical industry expanding internationally, especially through outsourcing of manufacturing to Contract Manufacturing Organizations (CMOs), production is now distributed across regions. This globalization requires uniform, compliant, and tamper-proof packaging that can ensure drug quality throughout long supply chains. As a result, packaging is no longer a local activity it has become a critical global function that must support international standards and logistics.
Cipla has developed and commercialized over 200 generic formulations and complex active pharmaceutical ingredients (APIs), which are currently exported to 62 countries across global markets. The increase in pharmaceutical production is not limited to traditional solid dosage forms. There is growing production of liquid drugs, injectables, biologics, biosimilars, and topical formulations, each requiring unique and often sophisticated packaging solutions. The diversification in drug forms has expanded the demand for customized packaging systems, such as glass vials, pre-filled syringes, temperature-controlled packaging, and child-resistant containers.
The pace of new pharmaceutical product introductions has accelerated notably in recent years. Between 2010 and 2019, the number of prescription drug launches rose by 60%, reflecting a sharp uptick in innovation and regulatory approvals. In 2023, the trend continued, with oncology accounting for 38% of all new product launches underscoring the industry's strategic focus on high-value, specialty therapeutics. Pharmaceutical companies are accelerating their drug development pipelines to respond to global health needs, such as chronic diseases, infectious diseases, and pandemics. The increase in new product launches including both prescription drugs and OTC products requires tailored packaging designs to ensure proper delivery, branding, patient adherence, and regulatory compliance. Each new product introduction amplifies the demand for specialized packaging formats and materials
Key Market Challenges
Stringent and Evolving Regulatory Requirements
Pharmaceutical packaging must meet strict international, national, and regional regulations to ensure drug safety, efficacy, and traceability. Regulatory bodies such as the U.S. FDA, European Medicines Agency (EMA), and World Health Organization (WHO) impose comprehensive rules regarding material selection, labeling, tamper-evidence, child resistance, and serialization.
Adhering to these stringent standards requires significant investment in testing, quality control, and certification. Small and mid-sized packaging companies often struggle to keep up with compliance requirements. New entrants face difficulties entering regulated markets due to complex approval processes and the need to demonstrate full regulatory compliance. Global pharmaceutical companies must tailor packaging for each market due to differing local regulations. This increases production complexity, time-to-market, and costs.
While regulations ensure safety, they also add layers of cost and complexity, which may slow down innovation, deter investment, and reduce the ability of manufacturers to scale globally.
Key Market Trends
Integration of Smart and Connected Packaging Solutions
The adoption of smart packaging technologies which combine traditional packaging with digital features like RFID tags, QR codes, NFC (Near Field Communication), time-temperature indicators, and even sensors is transforming pharmaceutical packaging into an active part of the drug delivery and monitoring process.
As counterfeiting becomes a growing concern in global pharmaceutical supply chains, smart packaging enables real-time authentication and track-and-trace systems that help verify the origin, condition, and authenticity of medicines. Packaging embedded with digital tools can provide reminders, usage instructions, and refill alerts through smartphones, significantly improving medication adherence especially for chronic disease and elderly patients. Connected packaging offers manufacturers and healthcare providers access to usage data, environmental exposure history (e.g., temperature, humidity), and supply chain movement, which can optimize logistics and pharmacovigilance efforts.
Smart packaging is evolving from a luxury feature to a competitive differentiator, particularly in high-value therapies such as biologics and specialty drugs. It opens new revenue streams, encourages brand loyalty, and aligns with the industry's push toward digitally enabled healthcare.
Key Market Players
Amcor plc
Becton, Dickinson, and Company
AptarGroup, Inc
Drug Plastics & Glass Co., Inc
Gerresheimer AG
Schott AG
O-I Glass, Inc.
West Pharmaceutical Services, Inc
WestRock Company
SGD Pharma
Report Scope:
In this report, the Global Pharmaceutical Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pharmaceutical Packaging Market, By Material:
Plastics & Polymers
Paper & Paperboard
Glass
Aluminium Foil
Others
Pharmaceutical Packaging Market, By Product:
Primary
Secondary
Tertiary
Pharmaceutical Packaging Market, By Drug Delivery:
Oral Drugs
Injectables
Topical
Ocular/ Ophthalmic
Nasal
Pulmonary
Transdermal
IV Drugs
Others
Pharmaceutical Packaging Market, By End Use:
Pharma Manufacturing
Contract Packaging
Retail Pharmacy
Institutional Pharmacy
Pharmaceutical Packaging Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Packaging Market.
Available Customizations:
Global Pharmaceutical Packaging market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Impact of COVID 19 on Pharmaceutical Packaging Market
5. Pharmaceutical Packaging Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminium Foil, Others)
5.2.2. By Product (Primary, Secondary, Tertiary)
5.2.3. By Drug Delivery (Oral Drugs, Injectables, Topical, Ocular/ Ophthalmic, Nasal, Pulmonary, Transdermal, IV Drugs, Others)
5.2.4. By End Use (Pharma Manufacturing, Contract Packaging, Retail Pharmacy, Institutional Pharmacy)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Pharmaceutical Packaging Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Material
6.2.2. By Product
6.2.3. By Drug Delivery
6.2.4. By End Use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmaceutical Packaging Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Material
6.3.1.2.2. By Product
6.3.1.2.3. By Drug Delivery
6.3.1.2.4. By End Use
6.3.2. Canada Pharmaceutical Packaging Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Material
6.3.2.2.2. By Product
6.3.2.2.3. By Drug Delivery
6.3.2.2.4. By End Use
6.3.3. Mexico Pharmaceutical Packaging Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Material
6.3.3.2.2. By Product
6.3.3.2.3. By Drug Delivery
6.3.3.2.4. By End Use
7. Europe Pharmaceutical Packaging Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Material
7.2.2. By Product
7.2.3. By Drug Delivery
7.2.4. By End Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Pharmaceutical Packaging Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Material
7.3.1.2.2. By Product
7.3.1.2.3. By Drug Delivery
7.3.1.2.4. By End Use
7.3.2. United Kingdom Pharmaceutical Packaging Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Material
7.3.2.2.2. By Product
7.3.2.2.3. By Drug Delivery
7.3.2.2.4. By End Use
7.3.3. Italy Pharmaceutical Packaging Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Material
7.3.3.2.2. By Product
7.3.3.2.3. By Drug Delivery
7.3.3.2.4. By End Use
7.3.4. France Pharmaceutical Packaging Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Material
7.3.4.2.2. By Product
7.3.4.2.3. By Drug Delivery
7.3.4.2.4. By End Use
7.3.5. Spain Pharmaceutical Packaging Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Material
7.3.5.2.2. By Product
7.3.5.2.3. By Drug Delivery
7.3.5.2.4. By End Use
8. Asia-Pacific Pharmaceutical Packaging Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Material
8.2.2. By Product
8.2.3. By Drug Delivery
8.2.4. By End Use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pharmaceutical Packaging Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Material
8.3.1.2.2. By Product
8.3.1.2.3. By Drug Delivery
8.3.1.2.4. By End Use
8.3.2. India Pharmaceutical Packaging Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Material
8.3.2.2.2. By Product
8.3.2.2.3. By Drug Delivery
8.3.2.2.4. By End Use
8.3.3. Japan Pharmaceutical Packaging Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Material
8.3.3.2.2. By Product
8.3.3.2.3. By Drug Delivery
8.3.3.2.4. By End Use
8.3.4. South Korea Pharmaceutical Packaging Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Material
8.3.4.2.2. By Product
8.3.4.2.3. By Drug Delivery
8.3.4.2.4. By End Use
8.3.5. Australia Pharmaceutical Packaging Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Material
8.3.5.2.2. By Product
8.3.5.2.3. By Drug Delivery
8.3.5.2.4. By End Use
9. South America Pharmaceutical Packaging Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Material
9.2.2. By Product
9.2.3. By Drug Delivery
9.2.4. By End Use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pharmaceutical Packaging Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Material
9.3.1.2.2. By Product
9.3.1.2.3. By Drug Delivery
9.3.1.2.4. By End Use
9.3.2. Argentina Pharmaceutical Packaging Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Material
9.3.2.2.2. By Product
9.3.2.2.3. By Drug Delivery
9.3.2.2.4. By End Use
9.3.3. Colombia Pharmaceutical Packaging Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Material
9.3.3.2.2. By Product
9.3.3.2.3. By Drug Delivery
9.3.3.2.4. By End Use
10. Middle East and Africa Pharmaceutical Packaging Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Material
10.2.2. By Product
10.2.3. By Drug Delivery
10.2.4. By End Use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pharmaceutical Packaging Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Material
10.3.1.2.2. By Product
10.3.1.2.3. By Drug Delivery
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia Pharmaceutical Packaging Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Material
10.3.2.2.2. By Product
10.3.2.2.3. By Drug Delivery
10.3.2.2.4. By End Use
10.3.3. UAE Pharmaceutical Packaging Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Material
10.3.3.2.2. By Product
10.3.3.2.3. By Drug Delivery
10.3.3.2.4. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Pharmaceutical Packaging Market: SWOT Analysis
